Study Assessing QBS72S For Treating Brain Metastases
Trial ID or NCT#
NCT05305365
Status
RECRUITING
Purpose
This study is to evaluate the efficacy and safety of QBS72S in participants with advanced, relapsed, metastatic cancer with CNS involvement
Official Title
Phase IIa Study Assessing QBS72S For Treating Brain Metastases
Eligibility Criteria
Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Exclusion Criteria:
Investigator(s)
Melanie Hayden Gephart
Neurosurgeon
Professor of Neurosurgery and, by courtesy, of Neurology and Neurological Sciences
Steven D. Chang, MD
Neurosurgeon,
Aneurysm neurosurgeon,
Cerebrovascular neurosurgeon,
Pituitary tumors neurosurgeon,
Stereotactic neurosurgeon
Robert C. and Jeannette Powell Neurosciences Professor and, by courtesy, of Otolaryngology - Head & Neck Surgery (OHNS) and of Neurology and Neurological Sciences
GordonÌýLi, MD
Neurosurgeon
Professor of Neurosurgery and, by courtesy, of Neurology and Neurological Sciences and of Otolaryngology - Head & Neck Surgery (OHNS)
Seema Nagpal, MD
Neuro-oncologist
Clinical Professor, Adult Neurology
Clinical Professor (By courtesy), Neurosurgery
Reena Thomas, MD PhD
Neuro-oncologist
Clinical Professor, Adult Neurology
Clinical Professor (By courtesy), Neurosurgery
Michael Lim, M.D.
Neurosurgeon,
Neurosurgeon
Stanford Medicine Endowed Chair of the Department of Neurosurgery, Professor of Neurosurgery and, by courtesy, of Radiation Oncology, of Medicine, of Otolaryngology - Head & Neck Surgery (OHNS) and of Neurology and Neurological Sciences
Contact us to find out if this trial is right for you.
Contact
Brandon Carlson-Clarke
(650) 724-5726
View on